Brief: aap Implantate Resolves Capital Increase

aap Implantate AG

27/09/2021 07:29

Sept 27 (Reuters) - AAP IMPLANTATE AG  AAQ1k.DE :
    * RESOLVES ON CAPITAL INCREASE WITH SUBSCRIPTION RIGHTS TO
FINANCE
SALES GROWTH AND START OF HUMAN CLINICAL STUDY FOR ANTIBACTERIAL
SILVER COATING TECHNOLOGY
    * SHARE CAPITAL SHALL BE INCREASED BY UP TO EUR 1,500,000.00
BY
ISSUING UP TO 1,500,000 NEW NO-PAR VALUE BEARER SHARES FROM
CURRENT AMOUNT OF EUR 3,478,243.00 TO UP TO EUR 4,978,243.00
    * NEW SHARES SHALL BE OFFERED TO SHAREHOLDERS OF COMPANY AT
A
SUBSCRIPTION PRICE OF EUR 3.30 PER NEW SHARE BASED ON A
SUBSCRIPTION RATIO OF 2.3189:1
    * NEW SHARES ARE ENTITLED TO PARTICIPATE IN DIVIDENDS AS OF
1
JANUARY 2021
    * SUBSCRIPTION PERIOD IS EXPECTED TO START ON 4 OCTOBER 2021
AND
TO END ON 18 OCTOBER 2021

Source text for Eikon:  ID:nEQbfWMY8a 
Further company coverage:  AAQ1k.DE 

 (Gdansk Newsroom)
 ((Gdansk.Newsroom@thomsonreuters.com;))